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Tuesday, February 5, 2013 359agating in human CaV1.2 channels, we have optically tracked the activation of
the S4 helices of repeats I, III and IV by site-directed fluorescent labeling of
introduced Cysteines with thiol-reactive probes. The channels were co-
expressed with their modulatory subunits b3 and a2d in Xenopus oocytes. Ionic
current and fluorescence emission were simultaneously recorded using the cut-
open oocyte voltage clamp fluorometry technique. Prior voltage-clamp, oo-
cytes were injected with 100 nl 80 mM BAPTA.4K, to prevent the activation
of endogenous Ca2þ-gated Cl channels. The extracellular solution contained
2 mMBa2þ or 10 mMCa2þ as charge carrier. Gating currents were recorded by
replacing Ca2þ or Ba2þ with Co2þ. 0.1 mM ouabain was added to abolish Naþ/
Kþ ATPase non-linear charge movement. Voltage-dependent fluorescence
changes (DF) were reported by fluorophores attached to substituted Cysteines
at the extracelular end of the S4 segment in repeats I, III and IV, tracking local,
voltage-dependent conformational rearrangements. The voltage dependence of
observed fluorescence deflections preceded ionic activation, reporting repeat-
specific VSD transitions taking place during shut states of the channel. Pro-
longed sojourns at depolarized potentials (þ50 mV) shifted the voltage-
dependence of reported DF to more hyperpolarized potentials by >50mV, re-
capitulating previously-characterized gating current properties. In summary,
we report the first optical characterization of VSD conformational changes in
a human voltage-gated Ca2þ channel, revealing repeat-specific voltage- and
time-dependent properties.
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Ca2þ influx through L-type (CaV1.2) channels in heart regulates excitation-
contraction (EC) coupling, action potential duration, and gene expression.
This versatility of L-type channels in heart is hypothesized to be mediated
in part by differential sub-cellular compartmentalization and hormonal modu-
lation of distinct CaV1.2 channel pools in cardiac myocytes. Such prevailing
hypotheses are best tested directly in cardiac myocytes, since their unique
cyto-architecture and signaling environment cannot be replicated in heterolo-
gous cells. There are two major hurdles: first, the large size of pore-forming
a1C subunits exceeds the packaging capacity of viral vectors, necessary to
express exogenous CaV1.2 channels in adult cardiac myocytes; second,
endogenous channels are a source of confounding contaminating signals. To
overcome these limitations, we focused on functionally reconstituting two
separately expressed moieties of the channel using a novel split-intein-
mediated protein splicing approach. In HEK 293 cells, split-intein fragments
were trans spliced to generate full-length a1C as determined by Western
blot. When co-expressed with auxiliary b subunits, trans-spliced a1C trafficked
normally to the cell surface and yielded robust whole-cell currents (ICa). The
split-intein fragments were readily incorporated into adenoviral vectors which
when used to infect adult myocytes yielded trans-spliced a1C that was detected
at the cell surface. To isolate exogenous ICa, we introduced mutations that
reduced dihydropyridine sensitivity of trans-spliced a1C (a1CDHP-). In the pres-
ence of 10 mM nifedipine, myocytes expressing trans-spliced a1CDHP- yielded
significantly larger currents than controls expressing trans-spliced a1C. The
results demonstrate a novel approach to robustly engineer the pore-forming
a1C subunit composition of CaV1.2 channels in cardiac myocytes, removing
a longstanding technical obstacle to L-type channel structure-function studies
in heart.Platform: Protein Assemblies & Aggregates
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Islet amyloid polypeptide (IAPP, Amylin) is responsible for amyloid formation
in type 2 diabetes and in islet cell transplants. The mechanism of IAPP toxicity
is poorly understood. Here we identify and characterize the toxic species
produced during amyloid formation by human IAPP. using a combination of
time-dependent biophysical and biological assays, we show that the transiently
populated pre-fibrillar intermediates formed in the early phase of amyloid
formation are toxic and they are loosely packed with very modest amountsof secondary structure. The only known natural mutation found in mature
human IAPP is a Ser20-to-Gly mis-sense mutation, which appears to be asso-
ciated with an increased risk of early-onset type 2 diabetes. We demonstrate
that the mutant accelerates amyloid formation under physiologically relevant
conditions. We rationally design another variant at residue 20, S20K-IAPP,
which is much slower to aggregate with an 18-fold longer lag phase and inhibits
wild type amyloid formation. The pronounced effects of the Ser20 mutants
highlight the sensitivity of amyloid formation to the identity of position 20.
By comparing the kinetics and toxicity profiles of the two Ser20 mutants to
wild type IAPP, we demonstrate that changes in the length of the lag phase
directly correlate with changes in the onset and the duration of toxicity. Our
findings provide direct evidence that the toxic species are transient intermedi-
ates and have implications for the treatment of type 2 diabetes and other
amyloid related diseases.
1842-Plat
Solid-State NMR Study of Pathologically Relevant Amylioid Intermediate
of 42-Residue Alzheimer’S Beta
Sudhakar Parthasarathy1, Masafumi Inoue2,3, Yiling Xiao1, Minako Hoshi3,4,
Yoshitaka Ishii1.
1Department of Chemistry, University Illinois at Chicago, Chicago, IL, USA,
2TAO Health Life Pharma Co. Ltd., Kobe, Japan, 3Institute of Biomedical
Research and Innovation, Kobe, Japan, 4Department of Anatomy and
Developmental Biology, Graduate School of Medicine, Kyoto University,
Kyoto, Japan.
Accumulating evidences suggest that many neurodegenerative diseases includ-
ing Alzheimer’s disease (AD) are linked with cytotoxic diffusible aggregates of
amyloid proteins, which are metastable intermediate species in protein misfold-
ing. Despite increasing importance of the amyloid intermediates, very little has
been known on their structures, relationship with amyloid fibril, and pathogenic
functions. This work presents a site-specific structural study on an intermediate
called amylo-spheroid (ASPD)(1) for 42-residue Alzheimer’s b (Ab(1-42)) by
solid-state NMR (SSNMR), which offers means to characterize metastable
amyloid intermediates.(2) As the ASPD level in a brain correlates with the se-
verity of AD, ASPD is likely an intermediate pathogenically relevant to AD.(1)
We demonstrate that detailed structural examination by 13C SSNMR is possible
on synthetic ASPD that well mimics native ASPD isolated from a brain extract
from an AD patient. Electron micrograph and immunological analyses using an
ASPD-specific ‘‘conformational’’ antibody confirm that morphologies and con-
formations of the synthetic ASPD used for the present NMR analysis are sim-
ilar to native ASPD. 13C SSNMR chemical-shift analysis over 20 residues
demonstrated that ASPD is made of a homogeneous conformer that is largely
composed of b-sheet structure. An inter-strand 13CO-13CO distance measure-
ment suggests that the ASPD involves a parallel b-sheet arrangement despite
the fact that ASPD does not bind to fibril-specific dyes such as thioflavin-T.
The structural features of ASPD will be compared with those of amyloid fibril
for Ab(1-42), which were elucidated by SSNMR analysis. The approach pre-
sented here is likely to open an avenue to examine structural details of various
amyloid intermediate species pathologically relevant to AD or other amyloid
diseases, for which structures have been poorly characterized.
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The proteolytic cleavage of the transmembrane amyloid precursor protein (APP)
produces amyloid-b peptides (Ab) that vary from 38 to 43 amino acids in length.
Two of these peptides, Ab1-40 and Ab1-42, are the major components of the ex-
tracellular amyloid plaques characteristic of Alzheimer’s disease (AD). Within
these plaques, the Ab is found aggregated into long polymeric assemblies rich in
b-sheet structure that are known as amyloid fibrils. Although the correlation
between plaque load and disease severity is poor there is strong evidence that
small soluble oligomers of Ab formed during the early stages of the aggregation
process are the agents of AD-associated neurotoxicity (1). Single molecule
fluorescence techniques have the potential to resolve the size and structural
heterogeneity of these oligomers, which are often difficult to discern by ensem-
ble methods. Most importantly, they allow the characterisation of small oligo-
meric species at the nucleation stage of the aggregation as the structures of
amyloid seeds remain ambiguous (2). Equimolar mixtures of Ab1-42 singly
labelled with either HiLyteFluor-488 or HiLyteFluor-647 were studied using
